Harrison St snaps up largest private life sciences portfolio in the UK

Chicago-based alternative real estate investor Harrison Street has entered the UK biotech sector with the acquisition of a portfolio of five life sciences and innovation properties across the country for a price of around £250 mln (€300 mln).

Premium subscriber content – please log in to read more or take a free trial.


Latest news

Best read stories